Navigation Links
Cell Therapeutics, Inc. Reports First Quarter Accomplishments and Financial Results
Date:4/26/2011

SEATTLE, April 27, 2011 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI" or the "Company") (NASDAQ and MTA: CTIC) today reported accomplishments and financial results for the first quarter ended March 31, 2011.

"In the first quarter, we raised $50 million through two financings, advanced pixantrone into a confirmatory pivotal trial and acquired an exclusive license from Chroma Therapeutics Ltd. ("Chroma") to co-develop and market Chroma's drug candidate, tosedostat, in the Americas all while reducing operating expenses compared to the same period last year," said James A. Bianco, M.D., Chief Executive Officer of CTI. "In March, we received the day 120 list of questions from the European Medicines Agency ("EMA") for our Marketing Authorization Application ("MAA") for pixantrone in Europe and are pleased with the review progress and the potential for a recommendation from the EMA's Medicinal Product Committee before the end of this year. We also expect to hear from the Office of New Drugs ("OND") this quarter relating to our appeal of the decision made on our New Drug Application ("NDA") for pixantrone. With an impressive portfolio of novel phase III drug candidates and the potential for regulatory approval for pixantrone, this year could be a pivotal year for the Company."

Review of 2011 Key Accomplishments

  • Completed two financings at a total offering price of $50 million in the first quarter 2011
  • Entered into a co-development and license agreement with Chroma, which is located in the United Kingdom.  This agreement provides CTI with exclusive marketing and co-development rights to Chroma's drug candidate, tosedostat, in North, Central and South America. Tosedostat is an oral, tumor selective inducer of amino acid depletion responses that has demonstrated encouraging single agent anti-tumor responses in blood-related cancers and solid tumors in phase I-II clinical trials.
  • Initiated a pivotal trial of pixantrone for the trea
    '/>"/>

  • SOURCE Cell Therapeutics, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Vista Partners Updates Coverage on Opexa Therapeutics, Inc.; Maintains Target Price of $6.50
    2. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
    3. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End 2010 Financial Results on February 16
    4. Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
    5. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for Pixuvri®
    6. Veteran Pharmaceutical Executives Form New American Therapeutics, Inc.
    7. BioMolecular Therapeutics, a New Global Player in RNAi Therapeutics, Launches Company and Adds Key Advisors
    8. Precision Therapeutics, Inc. Named to Pittsburgh Business Times 2010 Top 100
    9. BioMarin Acquires ZyStor Therapeutics, Inc.
    10. Nonconformity of NOV002 Used in Phase 3 NSCLC Trial Sponsored by Novelos Therapeutics, Inc to NOV002 (Glutoxim(R)), Used in Phase 1/2 NSCLC and all Previous Trials
    11. Reportlinker Adds The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/30/2015)... Today, UBM China, a wholly owned subsidiary ... Tianyi Exhibition Co., Ltd. to jointly run the Health ... held concurrently with CWMEE 2016. This ... following MEDTEC China and DENTECH China, and fills its ... It,s also another concrete cooperative project in ...
    (Date:6/30/2015)...  July 4 th is this weekend, a time ... and people behind it. To help honor our current nation,s ... USA Medical Card, a leading provider of free ... empower independence for our disabled military veterans, police, firemen, and ... their prescriptions. "Due to USA ...
    (Date:6/30/2015)... 30, 2015  Marken, the leading clinical trial logistics ... industry, has been granted permission by the government to ... drug product in Korea.  This precedent-setting shipment has allowed ... to continue receiving their clinical trial drugs during the ... The emergency was caused by recent partial closures of ...
    Breaking Medicine Technology:UBM Joins Chengdu Tianyi to Hold CWMEE 2016 2UBM Joins Chengdu Tianyi to Hold CWMEE 2016 3Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Marken Delivers Direct To Patients During MERS Outbreak 2Marken Delivers Direct To Patients During MERS Outbreak 3
    ... , an industry-leading vendor of ambulatory healthcare software ... fastest-growing private companies in America. ... http://www.newscom.com/cgi-bin/prnh/20100817/INC5000LOGO ) The listing was published ... an exclusive compilation of the nation,s fastest-growing private ...
    ... 26 Wound Management Technologies, Inc. (OTC Bulletin Board: ... Wound Care Innovations, LLC has further expanded its rapidly ... the addition of Central Medical Systems to its already ... CMSI is the ideal type of distributor; they have ...
    Cached Medicine Technology:Pulse Makes the 2010 Inc. 5000 List of the Fastest-Growing Private Companies in America 2Wound Management Technologies Expands Distribution Foot Print in Florida with the Addition of Central Medical Systems 2Wound Management Technologies Expands Distribution Foot Print in Florida with the Addition of Central Medical Systems 3
    (Date:6/30/2015)... ... June 30, 2015 , ... The campaign aims to make ... the different forms of digestive disorders over 70 million Americans face and inspiring readers ... system in tip-top shape. , The print component of “Digestive Wellness” is distributed within ...
    (Date:6/30/2015)... ... June 30, 2015 , ... Experts estimate that up to ... Back pain can range from a dull, constant ache (chronic) to a sudden sharp ... epidural steroid injections, selective nerve root blocks and rhizotomy treatment, OPTIMAL Pain & ...
    (Date:6/30/2015)... ... , ... It has become fairly common to purchase fresh broccoli at the ... before cooking. Throwing out radish greens, beet leaves and chard stalks is pretty typical, ... takes a little knowledge and practice to use them. Josie's Organics is ...
    (Date:6/30/2015)... ... June 30, 2015 , ... New ... expedited through the use of new forms, according to attorneys handling Xarelto ... and the Short Form Complaint, “provide guidance” for plaintiffs’ attorneys in filing new ...
    (Date:6/30/2015)... ... 2015 , ... When it comes to volunteering abroad, not many people end ... be too high. However, there are affordable programs to be had such as those ... cost. One such volunteer named Uzma Aishah, a student at the International Medical University ...
    Breaking Medicine News(10 mins):Health News:Mediaplanet’s “Digestive Wellness” Campaign Urges You To Listen to What Your Stomach Is Telling You and Talk About It 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 3Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 2Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 3Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 4Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 2Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 3Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 2Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 3
    ... have worse physical and life-quality outcomes and slower recovery ... ,Orthopaedic injury, usually from transport accidents or ... Australia, according to the study published in the latest ... Professor Peter Cameron, Head of the Emergency and Trauma ...
    ... screening test for cervical cancer detects more abnormalities than ... published on bmj.com today. ,It could also ... might allow for longer intervals in-between testing, says Elizabeth ... conventional pap smears for cervical cancer has been around ...
    ... campaign may be on to list Taj Mahal in the ... enveloped in a haze of dust and smog. ... eventually turn the gleaming white Taj Mahal black, have raised ... historian with Agra University, says the Taj needs corrective treatment ...
    ... Inc. announced today that it has dosed its ... (Study 201) of ALT-2074, its lead glutathione peroxidase mimetic, ... that renders them at high risk for cardiovascular complications. ... to evaluate ALT-2074's ability to lower inflammatory cardiovascular biomarkers ...
    ... Board: AVGO), a late stage biotechnology company that develops ... the selection of the optimal dose of HD-02, ... Disease. ,This dose was determined in an ... and Dr. Diana Rosas of Massachusetts General Hospital (MGH), ...
    ... have found that Exercise has a similar effect to ... ,In a series of scientific reports, she ... why exercise can be a form of therapy for ... with an SSRI drug. ,The experiment studies ...
    Cached Medicine News:Health News:New Cervical Cancer Test Increases the Detection Rate of Abnormal Cells 2Health News:Alteon Initiates Phase 2 Trial of ALT-2074 in Diabetes and Haptoglobin 2-2 2Health News:Avicena to Advance Huntington's Disease Clinical Program into Phase III 2
    For the quantitative determination of Glycohemoglobin in blood....
    The BioCheck Ferritin ELISA is intended for the quantitative determination of ferritin in human serum. This assay is to be used in the diagnosis of diseases affecting iron metabolism....
    Rapid turn-around time, results in less than 4 hours...
    ... Bio-Rad isotopic anemia assays ... minimal ,pipetting steps for ... about the processes ,involved ... the benefit to your ...
    Medicine Products: